CERS2 and Huntington disease: CerS2 null mice show reduced abundances of very-long-chain sphingolipids.34 However, current knowledge of CerS relies heavily on murine studies.28,35,36 To date, few studies have examined the expression of CerS37 in human brain tissue or Huntington’s disease.